COVID-19 Blog

Microbix Presenting at Planet MicroCap Investment Conference

Oct 26, 2026

Meetings with Growth-Oriented Investors, October 27-29, 2026 MISSISSAUGA, CANADA, October 26, 2026 – Microbix Biosystems Inc. (TSX: MBX,…

Oct 19, 2026

Presenting Results of Novel Product for Validation & QC of HPV Assays MISSISSAUGA, CANADA, October 19, 2026 – Microbix…

Oct 6, 2026

Meetings with Growth-Oriented Investors, October 8, 2026 MISSISSAUGA, CANADA, October 6, 2026 – Microbix Biosystems Inc. (TSX: MBX, OTCQX:…

Sep 23, 2026

Meetings with Growth-Oriented Investors, September 25 to 27, 2026 MISSISSAUGA, CANADA, September 23, 2026 – Microbix Biosystems…

Sep 9, 2026

Product Lines for Support of Leading IVD Manufacturers MISSISSAUGA, CANADA, April 27, 2026 – Microbix Biosystems Inc. (TSX: MBX, OTCQX:…

Aug 13, 2026

Q3 Revenues of $4.1 million and Controlled Net Loss MISSISSAUGA, CANADA, August 13, 2026 – Microbix Biosystems Inc. (TSX: MBX,…

Aug 6, 2026

Microbix Schedules Release of Results for Q3 Fiscal 2026 Results Release and Webinar Discussion on Morning of August 13, 2026…

Jun 2, 2026

May 14, 2026

H1 Revenues of $7.6 million and Controlled Net Loss MISSISSAUGA, CANADA, May 14, 2026 – Microbix Biosystems Inc. (TSX: MBX, OTCQX:…

May 12, 2026